Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets
Status:
Not yet recruiting
Trial end date:
2024-07-12
Target enrollment:
Participant gender:
Summary
Comparative randomized, Single dose, Two-treatment, Four-period, Two-sequence, Replicate
Crossover Bioequivalence Study to determine the bioequivalence of Amlodipine / valsartan from
Amlodipine/Valsartan 10/160 film coated tablets and Exforge10/160 mg film coated tablets
(Novartis Pharma, USA).
Phase:
Phase 1
Details
Lead Sponsor:
International Bio service
Treatments:
Amlodipine Amlodipine, Valsartan Drug Combination Valsartan